STAT3 and gastric cancer: CCAT5 binds to the C-end domain of STAT3 and inhibits STAT3Y705 dephosphorylation mediated by SHP-1, thereby inducing STAT3 nuclear entry and metastatic activation, which promotes gastric cancer progression.